The argument for pharmaceutical policy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The argument for pharmaceutical policy. / Traulsen, Janine Morgall; Almarsdóttir, Anna Birna.

In: International Journal of Clinical Pharmacy, Vol. 27, No. 1, 02.2005, p. 7-12.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Traulsen, JM & Almarsdóttir, AB 2005, 'The argument for pharmaceutical policy', International Journal of Clinical Pharmacy, vol. 27, no. 1, pp. 7-12.

APA

Traulsen, J. M., & Almarsdóttir, A. B. (2005). The argument for pharmaceutical policy. International Journal of Clinical Pharmacy, 27(1), 7-12.

Vancouver

Traulsen JM, Almarsdóttir AB. The argument for pharmaceutical policy. International Journal of Clinical Pharmacy. 2005 Feb;27(1):7-12.

Author

Traulsen, Janine Morgall ; Almarsdóttir, Anna Birna. / The argument for pharmaceutical policy. In: International Journal of Clinical Pharmacy. 2005 ; Vol. 27, No. 1. pp. 7-12.

Bibtex

@article{539955e64f64447c94510a4074bc1737,
title = "The argument for pharmaceutical policy",
abstract = "Pharmaceutical policy is a global concern. It has become a hot political topic in most countries--developed as well as developing--and can be found on the agenda of international organizations such as WHO, OECD, EU, WTO and even the World Bank. Pharmaceutical policy affects everyone in the world of pharmacy and it is therefore imperative that it be understood, discussed and debated within the pharmacy profession and included in the curriculum of schools of pharmacy. This, the first article in a series, argues for the importance of the academic discipline of pharmaceutical policy analysis and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how pharmaceutical policy is made; pharmaceutical policy as a dynamic process; and the new public health as a global issue. The article ends with a short description of the remaining five articles in the series which will deal with important aspects of pharmaceutical policy. The topics include: economic pressures on health care systems; drug utilization from the clinical viewpoint (rational use of medicines); the impact of pharmaceutical policy on patients and the patient impact on pharmaceutical policy; the professional perspective; and finally the last article which deals with studying and evaluating pharmaceutical policy.",
keywords = "Drug Industry, Health Personnel, Health Policy, Legislation, Drug, Pharmaceutical Services, Politics, Public Health, Journal Article",
author = "Traulsen, {Janine Morgall} and Almarsd{\'o}ttir, {Anna Birna}",
year = "2005",
month = feb,
language = "English",
volume = "27",
pages = "7--12",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - The argument for pharmaceutical policy

AU - Traulsen, Janine Morgall

AU - Almarsdóttir, Anna Birna

PY - 2005/2

Y1 - 2005/2

N2 - Pharmaceutical policy is a global concern. It has become a hot political topic in most countries--developed as well as developing--and can be found on the agenda of international organizations such as WHO, OECD, EU, WTO and even the World Bank. Pharmaceutical policy affects everyone in the world of pharmacy and it is therefore imperative that it be understood, discussed and debated within the pharmacy profession and included in the curriculum of schools of pharmacy. This, the first article in a series, argues for the importance of the academic discipline of pharmaceutical policy analysis and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how pharmaceutical policy is made; pharmaceutical policy as a dynamic process; and the new public health as a global issue. The article ends with a short description of the remaining five articles in the series which will deal with important aspects of pharmaceutical policy. The topics include: economic pressures on health care systems; drug utilization from the clinical viewpoint (rational use of medicines); the impact of pharmaceutical policy on patients and the patient impact on pharmaceutical policy; the professional perspective; and finally the last article which deals with studying and evaluating pharmaceutical policy.

AB - Pharmaceutical policy is a global concern. It has become a hot political topic in most countries--developed as well as developing--and can be found on the agenda of international organizations such as WHO, OECD, EU, WTO and even the World Bank. Pharmaceutical policy affects everyone in the world of pharmacy and it is therefore imperative that it be understood, discussed and debated within the pharmacy profession and included in the curriculum of schools of pharmacy. This, the first article in a series, argues for the importance of the academic discipline of pharmaceutical policy analysis and the involvement of pharmacists in this endeavour. The aim of the authors is to stimulate an informed and critical appreciation of this field. The authors begin with an introduction to the field of pharmaceutical policy, introducing several important concepts and current trends including: medicines regulation; how pharmaceutical policy is made; pharmaceutical policy as a dynamic process; and the new public health as a global issue. The article ends with a short description of the remaining five articles in the series which will deal with important aspects of pharmaceutical policy. The topics include: economic pressures on health care systems; drug utilization from the clinical viewpoint (rational use of medicines); the impact of pharmaceutical policy on patients and the patient impact on pharmaceutical policy; the professional perspective; and finally the last article which deals with studying and evaluating pharmaceutical policy.

KW - Drug Industry

KW - Health Personnel

KW - Health Policy

KW - Legislation, Drug

KW - Pharmaceutical Services

KW - Politics

KW - Public Health

KW - Journal Article

M3 - Journal article

C2 - 15861928

VL - 27

SP - 7

EP - 12

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 1

ER -

ID: 170601708